Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer von Sandler, Alan, Gray, Robert, Perry, Michael C, Brahmer, Julie, Schiller, Joan H, Dowlati, Afshin, Lilenbaum, Rogerio, Johnson, David H

Volltext

Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non–Small-cell Lung Cancer von Bordoni, Rodolfo, Ciardiello, Fortunato, von Pawel, Joachim, Cortinovis, Diego, Karagiannis, Thomas, Ballinger, Marcus, Sandler, Alan, Yu, Wei, He, Pei, Matheny, Christina, Felizzi, Federico, Rittmeyer, Achim

Volltext

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer von HANNA, Nasser, BUNN, Paul A, HARIHARAN, Subramanian, WANG, Benjamin, SANDIER, Alan, LONGER, Corey, EINHORN, Lawrence, GUTHRIE, Troy, BECK, Thaddeus, ANSARI, Rafat, ELLIS, Peter, BYRNE, Michael, MORRISON, Mark

Volltext

Invisible Barriers to Clinical Trials: The Impact of Structural, Infrastructural, and Procedural Barriers to Opening Oncology Clinical Trials von DILTS, David M, SANDIER, Alan B

Volltext

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib von MILLER, Vincent A, RIELY, Gregory J, HERBST, Roy S, HELLER, Glenn, LADANYI, Marc, PAO, William, JOHNSON, David H, ZAKOWSKI, Maureen F, LI, Allan R, PATEL, Jyoti D, HEELAN, Robert T, KRIS, Mark G, SANDIER, Alan B, CARBONE, David P, TSAO, Anne

Volltext

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer von HEYMACH, John V, PAZ-ARES, Luis, BONOMI, Philip D, HERBST, Roy S, KREBS, Annetta D, VASSELLI, James, JOHNSON, Bruce E, DE BRAUD, Filippo, SEBASTIAN, Martin, STEWART, David J, EBERHARDT, Wilfried E. E, RANADE, Anantbhushan A, COHEN, Graham, TRIGO, Jose Manuel, SANDIER, Alan B

Volltext

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy von VANSTEENKISTE, Johan, LARA, Primo N, PECK, Ronald, EDELMAN, Mark, LE CHEVALIER, Thierry, BRETON, Jean-Luc, BONOMI, Philip, SANDIER, Alan B, SOCINSKI, Mark A, DELBALDO, Catherine, MCHENRY, Brent, LEBWOHL, David

Volltext

Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program von DILTS, David M, SANDIER, Alan B, CHENG, Steven K, CRITES, Joshua S, FERRANTI, Lori B, WU, Amy Y, FINNIGAN, Shanda, FRIEDMAN, Steven, MOONEY, Margaret, ABRAMS, Jeffrey

Volltext

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer von Keedy, Vicki L., Sandler, Alan B.

Volltext

Processes to Activate Phase III Clinical Trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B von DILTS, David M, SANDIER, Alan B, SCOGGINS, Maren, WU, Amy, KAI ZHOU, SCHILSKY, Richard L, BAKER, Matthew, CHENG, Steven K, GEORGE, Stephen L, KARAS, Kathleen S, MCGUIRE, Stephen, MENON, Gourija S, REUSCH, Jason, SAWYER, Debbie

Volltext

Phase II Trial of Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Trial 1597 von MASTERS, Gregory A, DECLERCK, Lieven, BLANKE, Charles, SANDIER, Alan, DEVORE, Russell, MILLER, Kathy, JOHNSON, David

Volltext

Cytoplasmic Clusterin Expression Is Associated with Longer Survival in Patients with Resected Non–Small Cell Lung Cancer von ALBERT, Jeffrey M, GONZALEZ, Adriana, PUTNAM, Joe B, JOHNSON, David H, BO LU, MASSION, Pierre P, HEIDI CHEN, OLSON, Sandra J, SHYR, Yu, DIAZ, Roberto, LAMBRIGHT, Eric S, SANDIER, Alan, CARBONE, David P

Volltext

E-66. Clinical experience with Tarceva von Sandier, Alan B.

Volltext

Angiogenesis and lung cancer : Prognostic and therapeutic implications: Lung cancer von HERBST, Roy S, ONN, Amir, SANDIER, Alan

Volltext

Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous Therapies von GOVINDAN, Ramaswamy, CROWLEY, John, SCHWARTZBERG, Lee, KENNEDY, Peter, WILLIAMS, Charles, EKSTRAND, Bradley, SANDIER, Alan, JAUNAKAIS, Dinah, BOLEJACK, Vanessa, GHALIE, Richard

Volltext

Targeting Angiogenesis in Lung Cancer von Sandler, Alan B.

Volltext

A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects von Sandler, A N, Baxter, A D, Katz, J, Samson, B, Friedlander, M, Norman, P, Koren, G, Roger, S, Hull, K, Klein, J

Volltext

COX-2 inhibition and lung cancer: The role of COX-2 carcinogenesis von SANDIER, Alan B, DUBINETT, Steven M

Volltext

Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy von Devereaux, Benedict M., LeBlanc, Julia Kim, Yousif, Edward, Kesler, Kenneth, Brooks, JoAnn, Mathur, Praveen, Sandler, Alan, Chappo, John, Lehman, Glen A., Sherman, Stuart, Gress, Frank, Ciaccia, Donato

Volltext

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors von KOBAYASHI, Hiroyuki, GAIL ECKHARDT, S, WOLIN, Maurice, BASCHE, Michele L, LOCKRIDGE, Jennifer A, ROTHENBERG, Mace L, SANDIER, Alan B, O'BRYANT, Cindy L, COOPER, Wendy, HOLDEN, Scott N, AITCHISON, Roger D, USMAN, Nassim

Volltext